Quest Lover / Teams welcome
Support clinicians in decision-making processes through easy access of mutation dependent targeted therapy options by using NLP.
Apply until Nov 30, 2020 / Xplorers Camp on Dec 8, 2020
Are you curious to deep-dive into one of the most commonly used genomics cancer portals in the scientific community and investigate how to incorporate self-created NLP workflows to get further evidence for molecular-guided therapy options?
The cBioPortal is one of the most commonly used cancer genomics platforms. Some hospitals adapt the platform and customize it to use it in their clinical decision making process. In this challenge we want to include results from natural language processing that are able to provide further evidence for molecular guided therapy options into the platform. Part of the task will be to understand the architectural setup in order to derive options on how to best integrate NLP results. The challenge will be conducted in a real clinical setting of a German hospital.
Dr. Lars Hummerich
Head of Oncology Innovations, Roche Diagnostics Deutschland GmbH
Dr. Markus Bundschus
Head RDG Data Office
Preferred scale: 3-6 months full-time (flexible models are also possible), several persons could work simultaneously on the topic
Possible formats: from working student to internship to bachelor or master thesis…and even bigger, if your idea requires a larger engagement.
By sending this to us via the submit button you agree to the following:
you confirm that you are the author of the submission and entitled to dispose of rights of use and exploitation of the contents of your submission, and that you have not yet granted any rights of use and exploitation to third parties that would be infringed by your submission;
you grant to Roche Diagnostics GmbH the unrestricted, sublicensable and exclusive right to use and exploit your submission by all means known today or in the future. This includes without limitation the rights to reproduce, distribute, and exhibit your submission, as well as the right to communicate your submission to the public. You also grant to Roche Diagnostics GmbH the right to edit the submission, to translate it, and to create abbreviations and summaries (abstracts); the aforesaid rights to use and exploit also apply to such edited versions, translations, abbreviations and summaries.
Roche Diagnostics GmbH will designate you as the author of the submission, and will recognize and respect your moral rights in the submission.
Any problems with the submit button? Please send your submission to healthcare.xplorers@roche.com.
Further information on our privacy policy can be found here.
Any problems with the submit button?
Please send your submission to healthcare.xplorers@roche.com.
Further information on our privacy policy can be found here.